Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L F Gram

Showing results (111-120 of 197) with videos related to

Pageof 20
Sort By:
European Journal of Clinical Pharmacology|January 1, 1994
Glucuronidation clearance of 8-hydroxyclomipramine in relation to sparteine and mephenytoin phenotypeK K Nielsen, K Brøsen, M G Hansen, et al.
Therapeutic Drug Monitoring|September 1, 1991
Concentration-response relationship in paroxetine treatment of diabetic neuropathy symptoms: a patient-blinded dose-escalation studyS H Sindrup, E Grodum, L F Gram, et al.
Acta Psychiatrica Scandinavica|January 10, 2002
Psychopharmacological treatment and psychiatric morbidity in 390 cases of suicide with special focus on affective disordersU A Andersen, M Andersen, J U Rosholm, et al.
British Journal of Clinical Pharmacology|February 1, 1984
Suppression of plasma cortisol after oral administration of oxazepam in manL F Gram, L Christensen, C B Kristensen, et al.
Clinical Pharmacology and Therapeutics|May 1, 1994
Single-dose kinetics of clomipramine: relationship to the sparteine and S-mephenytoin oxidation polymorphismsK K Nielsen, K Brøsen, M G Hansen, et al.
Acta Psychiatrica Scandinavica|August 11, 2000
Contacts to the health care system prior to suicide: a comprehensive analysis using registers for general and psychiatric hospital admissions, contacts to general practitioners and practising specialists and drug prescriptionsU A Andersen, M Andersen, J U Rosholm, et al.
Ugeskrift for Laeger|March 6, 1989
[Nature and extension of drug information to general practitioners. A questionnaire study]L B Rotwitt, J U Rosholm, K Brøsen, et al.
Clinical Neuropharmacology|January 1, 1992
Pharmacogenetics in psychopharmacology: basic principles and clinical implicationsL F Gram, K Brøsen, S Sindrup, et al.
Clinical Neuropharmacology|January 1, 1992
Pharmacogenetics of tricyclic and novel antidepressants: recent developmentsK Brøsen, L F Gram, S Sindrup, et al.
Clinical Pharmacology and Therapeutics|June 1, 1995
Moclobemide, a substrate of CYP2C19 and an inhibitor of CYP2C19, CYP2D6, and CYP1A2: a panel studyL F Gram, T W Guentert, S Grange, et al.
Pageof 20

Showing results (111-120 of 197) with videos related to

Sort By:
Pageof 20
European Journal of Clinical Pharmacology|January 1, 1994
Glucuronidation clearance of 8-hydroxyclomipramine in relation to sparteine and mephenytoin phenotypeK K Nielsen, K Brøsen, M G Hansen, et al.
Therapeutic Drug Monitoring|September 1, 1991
Concentration-response relationship in paroxetine treatment of diabetic neuropathy symptoms: a patient-blinded dose-escalation studyS H Sindrup, E Grodum, L F Gram, et al.
Acta Psychiatrica Scandinavica|January 10, 2002
Psychopharmacological treatment and psychiatric morbidity in 390 cases of suicide with special focus on affective disordersU A Andersen, M Andersen, J U Rosholm, et al.
British Journal of Clinical Pharmacology|February 1, 1984
Suppression of plasma cortisol after oral administration of oxazepam in manL F Gram, L Christensen, C B Kristensen, et al.
Clinical Pharmacology and Therapeutics|May 1, 1994
Single-dose kinetics of clomipramine: relationship to the sparteine and S-mephenytoin oxidation polymorphismsK K Nielsen, K Brøsen, M G Hansen, et al.
Acta Psychiatrica Scandinavica|August 11, 2000
Contacts to the health care system prior to suicide: a comprehensive analysis using registers for general and psychiatric hospital admissions, contacts to general practitioners and practising specialists and drug prescriptionsU A Andersen, M Andersen, J U Rosholm, et al.
Ugeskrift for Laeger|March 6, 1989
[Nature and extension of drug information to general practitioners. A questionnaire study]L B Rotwitt, J U Rosholm, K Brøsen, et al.
Clinical Neuropharmacology|January 1, 1992
Pharmacogenetics in psychopharmacology: basic principles and clinical implicationsL F Gram, K Brøsen, S Sindrup, et al.
Clinical Neuropharmacology|January 1, 1992
Pharmacogenetics of tricyclic and novel antidepressants: recent developmentsK Brøsen, L F Gram, S Sindrup, et al.
Clinical Pharmacology and Therapeutics|June 1, 1995
Moclobemide, a substrate of CYP2C19 and an inhibitor of CYP2C19, CYP2D6, and CYP1A2: a panel studyL F Gram, T W Guentert, S Grange, et al.
Pageof 20